Because of its lower degradation rate and negligible hepatic clearance compared to insulin, C-peptide is a cornerstone for the assessment of non-diabetes-associated hypoglycemia and the diagnosis of conditions including insulinoma and factitious hypoglycemia [8]. This evidence concerns the gene INS and diabetes mellitus.